Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation

Clinical trial NCT04470076 · UNKNOWN

Trial details

NCT number: NCT04470076
Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Surgery EGFR Activating Mutation Chemotherapy EGFR TKI

Start date: 2020-07-10
Primary completion: 2021-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.